Back to top
more

Coherus Oncology, Inc. (CHRS)

(Delayed Data from NSDQ)

$1.50 USD

1.50
4,460,508

+0.02 (1.35%)

Updated Jun 26, 2026 04:00 PM ET

After-Market: $1.50 0.00 (0.00%) 7:58 PM ET

Zacks Rank:
Message not found:16923

3-Hold of 5     3    

Style Scores:
Message not found:17303

NA Value NA Growth NA Momentum NA VGM

Industry Rank:
Message not found:17304

Bottom 37% (154 out of 245)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Fundamental Charts

CHRS 1.50 +0.02(1.35%)

Will CHRS be a Portfolio Killer in June?

Zacks Investment Research is releasing its prediction for CHRS based on the 1-3 month trading system that more than doubles the S&P 500.

Click here - the CHRS analysis is free »